267 Attitudes towards male partner HIV testing among low-income, minority pregnant women and their partners Lynn M. Yee, Jenise Jackson, Karolina Leziak, Emily S. Miller
Northwestern University Feinberg School of Medicine, Chicago, IL OBJECTIVE: Maternal HIV seroconversion during pregnancy is a source of maternal morbidity and major risk factor for maternal to child HIV transmission. Primary prevention of maternal seroconversion requires knowledge of the HIV status of sexual partners, but testing rates, particularly among urban minority heterosexual males, remain low. We implemented a quality improvement program offering free male partner HIV testing in a low-income urban prenatal clinic but had poor uptake of testing. This study was initiated to understand the attitudes of pregnant women and their partners surrounding partner HIV testing. STUDY DESIGN: This is a qualitative study of non-Hispanic black and Hispanic pregnant women receiving publicly funded prenatal care in a large urban hospital located in a high HIV prevalence area and their partners. All English-speaking pregnant women and their partners were eligible for in-depth individual interviews about HIV testing. Semi-structured interview guides were used to elicit participant attitudes. Analysis was organized by whether participants desired or declined partner HIV testing. De-identified transcripts were analyzed using the constant comparative method to determine themes and subthemes. Individuals were recruited until analysis achieved saturation. RESULTS: Of 45 total participants, 26 were pregnant women and 19 were male partners of female participants. Two-thirds of participants (18 women and 12 men) desired male partner HIV testing. Reasons for desiring or declining HIV testing aligned within three major themes within each patient type: risk perception, logistical, and testing history. Exemplary quotations for each theme are shown in Table 1 . Subthemes organized by male and female participant preferences are found in Table 2 . One cross-cutting theme was of the pregnant woman taking responsibility for the health of the family, which could serve as either a motivator to test (e.g. male willingness to test due to female request) or reason to decline (e.g. male perception that female test was sufficient and confirmed his negative status). CONCLUSION: Pregnant women are often the linchpin of prevention of horizontal and vertical HIV transmission in the family unit. These data inform strategies to engage pregnant women and their partners in high prevalence areas to improve implementation of partner HIV testing in the prenatal setting. OBJECTIVE: Limited data suggest magnesium sulfate infusion may be associated with deficits in information processing and memory, potentially due to side effects or alterations in cerebral vasodilation. As such changes may have implications in medical decision making, our objective was to determine if postpartum cognitive function (information processing speed and working memory capacity) differed based on receipt of magnesium sulfate in women with hypertensive disorders of pregnancy (HDP). STUDY DESIGN: In this prospective observational study, women with singleton gestations who were diagnosed with HDP at 34 weeks of gestation were enrolled on admission for delivery. Magnesium prophylaxis was administered at obstetrician discretion. During the postpartum hospitalization, women were administered two validated assessments of cognitive function: the Salthouse Digit Comparison (SDC), which measures speed of information processing, and the Size Judgment Span (SJS), which measures working memory capacity. Scores were analyzed as continuous measures and by quartile (of increasing cognitive function). Bivariable and multivariable analyses compared cognitive function scores based on active receipt of magnesium sulfate at the time of the interview. RESULTS: Of 336 enrolled women, 30.1% (N¼101) were receiving magnesium sulfate at the time of the cognitive function tests. Women on magnesium sulfate were more likely to be publicly insured (21.8% vs 10.7%, p¼0.007) and to have delivered at an earlier gestational age (37.8 vs 38.5 weeks, p<0.001). Compared to women not on magnesium sulfate, women receiving magnesium sulfate had significantly lower median scores for the SDC and the SJS (Table) . After adjusting for potential confounders, women on magnesium sulfate had significantly lower SDC scores (b -5.46, 95% CI -8.44 to -2.48) and lower odds of scoring in the highest SDC quartile (aOR 0.28, 95% CI 0.13-0.57). The SJS did not differ by whether women were receiving magnesium in multivariable analyses (Table) . CONCLUSION: Among women with HDP, active receipt of magnesium sulfate is associated with slower maternal processing speed but no significant differences in memory. These findings suggest women receiving magnesium sulfate may benefit from tailored counseling strategies or increased time to make decisions in order to optimize shared decision making and quality of care.
269 Differences in obstetric care and outcomes associated with shift change Lynn M. Yee for the Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network, Bethesda, MD OBJECTIVE: Intrapartum provider decision making and systems issues may affect obstetric quality of care. Our objective was to assess whether intrapartum obstetric interventions and adverse outcomes differ based on proximity of delivery to attending shift change. STUDY DESIGN: Secondary analysis from a multicenter observational obstetric cohort of >115,000 mother-baby pairs from 25 hospitals . Trained research personnel abstracted all records as well as site data, including time of provider shift changes. All women with cephalic, singleton live fetuses who attempted vaginal birth were eligible for inclusion. Women with known fetal anomalies or who delivered within 15 minutes of arrival were excluded. The primary exposure was a ratio of (time from most recent attending shift change to vaginal delivery or decision for cesarean delivery [CD] ) over (total length of shift). Ratios represent the proportion of time completed in the shift, standardized for varying shift lengths. A sensitivity analysis restricted to women delivered by physicians working 12 hour shifts was performed. Outcomes chosen a priori included CD, episiotomy, 3 rd /4 th degree perineal laceration, and 5-minute Apgar score <4. Chi-squared tests and generalized additive models were performed. RESULTS: Of 81,098 women eligible for inclusion, 52,279 (64.5%) had available ratio data and constituted the analyzable sample. Almost one third (32.7%) of women were delivered by physicians who worked 12 hour shifts. Deliveries were evenly distributed throughout shifts, with 49.9% taking place in the first half of shifts. CD frequency was highest near the beginning and at the end of shifts (p¼0.047) though the overall range was small (12.2% to 16.0%). Episiotomy (p¼0.66), major perineal laceration (p¼0.73), and 5-minute Apgar score <4 (p¼0.32) did not differ by time to next shift. Generalized additive models (Figure) demonstrated that CD frequency occurred in a statistically significant (p¼0.01) non-linear pattern confirming the highest frequency occurred at the beginning or end of shifts, but such patterns were not seen for other outcomes. Sensitivity analyses confirmed these findings.
